Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 2007 Oct;171(4):1168–1179. doi: 10.2353/ajpath.2007.070528

Oxidative Stress, Gene Expression, and Protein Changes Induced in the Human Placenta during Labor

Tereza Cindrova-Davies *, Hong-Wa Yung *, Jemma Johns , Olivera Spasic-Boskovic *, Svitlana Korolchuk *, Eric Jauniaux , Graham J Burton *, D Stephen Charnock-Jones
PMCID: PMC1988867  EMSID: UKMS1036  PMID: 17823277

Abstract

Malperfusion of the placenta has been implicated as a cause of oxidative stress in complications of human pregnancy, leading to release of proinflammatory cytokines and anti-angiogenic factors into the maternal circulation. Uterine contractions during labor are known to be associated with intermittent utero-placental perfusion. We therefore tested whether oxidative stress, proinflammatory cytokines, and angiogenic regulators were increased in placentas subjected to short (<5 hours) and long (>15 hours) labor compared with nonlabored controls delivered by cesarean section. In addition, broader changes in gene transcripts were assessed by microarray analysis. Oxidative stress, activation of the nuclear factor-κB pathway, tumor necrosis factor-α and interleukin 1β all increased in placental tissues after labor. Stabilization of hypoxia-inducible factor-1α and increased vascular endothelial growth factor soluble receptor-1 were also observed. By contrast, tissue levels of placenta growth factor decreased. Apoptosis was also activated in labored placentas. The magnitude of these changes related to the duration of labor. After labor, 55 gene transcripts were up-regulated and 35 down-regulated, and many of these changes were reflected at the protein level. In conclusion, labor is a powerful inducer of placental oxidative stress, inflammatory cytokines, and angiogenic regulators. Our findings are consistent with intermittent perfusion being the initiating cause. Placentas subjected to labor do not reflect the normal in vivo state at the molecular level.


There is currently much interest in the role that placental oxidative stress plays in the pathophysiology of complications of human pregnancy.1,2,3 The cause of the oxidative stress is not certain, but the major complications of pregnancy have long been associated with deficient conversion of the uterine spiral arteries, suggesting that impaired perfusion of the placenta is the initiating insult.4,5,6,7 Deficient conversion results in the spiral arteries retaining more smooth muscle cells in their walls than normal, and we recently proposed that this leads to exaggerated intermittent perfusion of the placenta.8 Experiments involving hypoxia-reoxygenation of villous explants in vitro have supported this hypothesis, demonstrating that placental oxidative stress can be induced rapidly by an ischemia-reperfusion-type insult. Generation of oxidative stress is associated with activation of the p38 and SAPK MAPK, and the nuclear factor (NF)-κB signaling pathways; increased secretion and production of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β); and apoptotic changes localized principally to the syncytiotrophoblast.9,10,11,12,13 The finding that these changes can be blocked by antioxidants in vitro9 strongly suggests they are a response to increased production of reactive oxygen species.

However, the cellular events occurring during hypoxia-reoxygenation are complex because of the rapid rate of reaction of reactive oxygen species with scavengers and other biomolecules. Consequently, in vitro manipulations may not accurately reflect in vivo responses. It is not possible experimentally to induce changes in utero-placental perfusion in pregnant women for obvious ethical reasons. We therefore took advantage of the experiment-of-nature that occurs when an otherwise healthy placenta is subjected to intermittent blood supply during labor to assess the impact of ischemia-reperfusion in vivo on placental gene expression and cytokine profile. Uterine contractions cause compression of the uterine vasculature and, hence, transient reductions in uteroplacental blood flow.14,15,16 Recent Doppler ultrasound studies have demonstrated a linear inverse relationship between uterine artery resistance and the intensity of the uterine contractions during labor.14 The absence of end-diastolic flow is observed during contractions when the intrauterine pressure exceeds 35 mmHg.15 This intermittent perfusion can be expected to provide the basis for ischemia-reperfusion type injury of the placenta. As a result, conversion of xanthine dehydrogenase to xanthine oxidase (XD/O), a hallmark of ischemia-reperfusion injury, is enhanced in placental tissues after vaginal delivery compared with nonlabored cesarean controls.17 Analysis of placental energy metabolism also confirms significant ischemia during labor because there is a marked reduction in the tissue concentration of ATP, and of the ATP/ADP ratio, in placentas delivered vaginally compared with cesarean controls.18 In addition, labor is associated with a significant depletion of vitamin C in maternal plasma, amniotic fluid, and fetal plasma, indicating increased utilization of antioxidant pathways.19 Finally, umbilical venous and arterial samples of neonates born by vaginal delivery contain higher glutathione levels compared with those delivered by cesarean section (CS),20 and placental generation of lipid peroxide and superoxide are also enhanced.

The hemodynamic consequences of labor for the placenta are, however, potentially confounded by the endocrine stimuli that initiate the labor process. In most models of parturition, prostaglandins (PGs) are identified as the effector molecules for uterine contractions and cervical ripening. PG formation is known to be stimulated by proinflammatory cytokines that are secreted locally by intrauterine tissues. In preparation for labor, there is a switch in the myometrium from the production of prostacyclin, which suppresses uterine activity along with progesterone, to increased synthesis of PGE2 and PGF2α, which are uterotonic. These PGs arise via the action of cyclooxygenase (COX) enzymes, primarily via transcriptional up-regulation of the inducible isoform COX-2.21 Although these PGs are primarily uterotonic, they could also have an effect on placental gene expression. To separate the hemodynamic effects of labor from the stimuli initiating labor, we determined whether the responses were related to the duration of labor by investigating placentas subjected to short (<5 hours) and long labor (>15 hours).

The hypothesis tested in this study was that ischemia-reperfusion during labor stimulates oxidative stress, increased production of proinflammatory and anti-angiogenic cytokines, and apoptosis in placentas from vaginal deliveries compared with nonlabored cesarean controls. A panel of antibodies reflecting these protein changes has been chosen, based primarily on our previous in vitro findings.9 We also assessed the impact of the labor process on the broader pattern of placental gene expression using microarray analysis in the long labor samples.

Materials and Methods

Materials

Antibodies to the phosphorylated and total forms of IκB, Hsp27, TNF-α, cleaved caspase-3, and cleaved caspase-9 were from Cell Signaling Technology (Beverly, MA). Anti-COX-2 antibody was from Cayman Chemical (Ann Arbor, MI), anti-HNE from Axxora (Nottingham, UK), anti-Hsp90 from Stressgen Bioreagents Corp. (York, UK), anti-VEGF-R1 and PlGF from Abcam (Cambridge, UK), and anti-VEGF-A from Santa Cruz Biotechnology (Santa Cruz, CA). The horseradish peroxidase-conjugated secondary antibodies were from Amersham Biosciences (Bucks, UK). Alexa 488 and Alexa 568 fluorescently labeled antibodies were from Molecular Probes Invitrogen Detection Technologies (Leiden, The Netherlands), and biotinylated secondary antibodies were from Vector Laboratories (Peterborough, UK).

Tissue Collection

The study was approved by the local research ethics committees in Cambridge and London. Human term (38 to 41 weeks) placentas were obtained from normal uncomplicated pregnancies, with written informed patient consent, immediately after either elective nonlabored CS or vaginal delivery.

In patients delivering vaginally the start of labor was defined as the onset of regular uterine activity leading to dilatation of the cervix. Progress of labor was recorded using a partogram,22,23 and all patients progressed satisfactorily to a noninstrumented vaginal delivery. Placentas were collected from women delivering after <5 hours of total labor (short labor) and >15 hours (long labor). There was no evidence of ascending infection in the vaginal deliveries, and clinical details of the placentas used for protein analysis and immunohistochemistry (IHC) are presented in Table 1.

Table 1.

Clinical Details of the Placentas

Group MA (years) GA (weeks) Mode of delivery Reason for CS Labor stages (minutes) Baby’s weight (g)
CS 26 39 LSCS Previous LSCS 3800
CS 23 38 LSCS Two previous LSCS 4000
CS 30 39 LSCS Previous LSCS 3250
CS 32 39 LSCS Maternal request 3450
CS 28 38 LSCS Two previous LSCS 3900
SL 32 40 SVD 150, 90, 4 3880
SL 21 40 SVD 248, 20, 5 3820
SL 28 40 SVD 70, 9, 9 2750
SL 31 38 SVD 160, 3, 6 3080
SL 38 40 SVD 240, 40, 2 3820
LL 32 39 SVD 950, 85, 5 3830
LL 36 41 SVD 980, 35, 5 3940
LL 34 41 SVD 930, 35, 5 3640
LL 38 41 SVD 960, 30, 12 3460
LL 36 41 SVD 840, 115, 5 3680

CS, cesarean section; SL, short labor; LL, long labor; MA, maternal age; GA, gestational age; LSCS, low segment cesarean section; SVD, standard vaginal delivery. 

Samples (each ∼40 to 50 mg wet weight) were taken from two standardized sites midway between the chorionic and basal plates from lobules free of visible infarction, calcification, hematoma, or tears, and processed within 5 to 10 minutes of delivery. After a brief rinse in ice-cold phosphate-buffered saline, samples were either snap frozen in liquid nitrogen for mRNA and protein analysis (stored at −80°C until use) or fixed in 4% paraformaldehyde and embedded in wax for IHC.

Western Blots

Tissue homogenization to obtain protein lysates and subsequent sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting were performed as previously described.12 Proteins were revealed and quantified using Image J software (National Institutes of Health, Bethesda, MD; http://rsb.info.nih.gov/ij/). Membranes were reprobed with antibody recognizing β-actin to control for protein loading. The values are expressed as a percentage of the control lysate (100%) for each experiment. Sample number was restricted to five per group (CS, short labor, long labor) because it is only possible to compare between groups if the lysates are run on the same gel.

Colorimetric IHC

Paraformaldehyde-fixed tissues embedded in paraffin wax were sectioned at 7 μm. After dewaxing and blocking of endogenous peroxidases by incubation with 3% H2O2 for 30 minutes, the sections were incubated with nonimmune serum for 20 minutes. Primary antibodies were applied overnight at 4°C, and binding was detected using Vectastain Elite ABC kits (Vector Laboratories) and SigmaFast DAB (Sigma, Poole, Dorset, UK), according to the manufacturers’ instructions. Sections were lightly counterstained with hematoxylin. When necessary, antigen retrieval was performed before blocking using 0.01 mol/L sodium citrate buffer at pH 6.0 in a pressure cooker for 2 minutes. Negative controls were performed by replacement with equal concentrations of nonimmune or isotype-matched irrelevant control.

Fluorescent IHC

Sections were incubated with primary antibodies overnight as in the colorimetric protocol, washed, and incubated for 1 hour at room temperature with species-specific Alexa 488 or Alexa 568 secondary fluorescent antibodies (used at 1/200; Molecular Probes) in blocking buffer. Sections were washed in Tris-buffered saline and subsequently mounted in Vectashield mounting medium containing 4,6-diamidino-2-phenylindole (Vector Laboratories). Images were captured using a Leica confocal microscope (LeicaTCS-NT; Leica Instruments GmbH, Wetzlar, Germany).

RNA Isolation and Aminoallyl Reverse Transcription Labeling

Total RNA was isolated either from snap-frozen placental tissue or from tissue collected in RNA Later (Ambion, Inc., Austin, TX) using TRI reagent (Sigma). The RNA was quantified by spectrophotometry (Nanodrop Technologies, Wilmington, DE) and RNA integrity assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies UK Ltd., Stockport, Cheshire, UK). In brief, 20 μg of total RNA from each sample and the common reference RNA (a pool of equal masses of RNAs from 20 placentas) were reverse-transcribed using a master mix containing SuperScript II reverse transcriptase in the first strand buffer with 0.1 mol/L dithiothreitol (Invitrogen, Paisley, UK), 5 μg/μl oligo (dT)23 (Sigma), 50× aminoallyl dUTP/low dTTP dNTP mix (25 mmol/L dATP, 25 mmol/L dCTP, 25 mmol/L dGTP, 10 mmol/L dTTP, and 15 mmol/L aa-dUTP), and 20 U/μl RNaseOUT (Invitrogen). The cDNA was purified using a Microcon-30 filter (Millipore, Bedford, MA) and fluorescently labeled with either Cy-3 or Cy-5 monofunctional reactive dye (GE Health Care UK Ltd., Little Chalfont, Buckinghamshire, UK). Dye-labeled cDNAs were purified using a polymerase chain reaction (PCR) product purification kit (Qiagen Ltd., Crawley, West Sussex, UK) and dried before hybridization.

Microarray Analysis

Equal amounts of the labeled cDNAs were dissolved in hybridization buffer (40% deionized formamide, 5× Denhardt’s solution, 5× standard saline citrate, 50 mmol/L Tris-HCl, 0.1% sodium dodecyl sulfate, 1 mol/L sodium pyrophosphate, 4 mg/ml yeast tRNA, and 8 mg/ml Poly dA), boiled, and hybridized at 42°C for a minimum of 18 hours to custom human cDNA arrays (HMN1 and HMN2) representing ∼15,000 genes in total (http://www.path. cam.ac.uk/resources/microarray/microarrays/). After hybridization and washing, the arrays were scanned using an Axon 4100A scanner and the images analyzed using BlueFuse software (BlueGnome, Cambridge, UK). The raw data were normalized both within arrays and between arrays using the LIMMA software package (linear models of microarray data, http://bioinf.wehi.edu.au/limma/). Transcript abundance data were compared between cesarean control and prolonged labor samples using the popular Cyber-T algorithm.24 This algorithm is an unpaired t-test, modified by the inclusion of a Bayesian prior based on the variance of other transcripts in the data set25 and is widely used. For further statistical analysis, GeneSpring Expression Analysis software (Silicon Genetics, Redwood City, CA) was used. Gene ontologies were identified using Fatigo26 (http://www.fatigo.org). The transcripts identified as having significantly different abundance were analyzed using the Ingenuity Pathway Analysis package (Redwood, CA). The MIAME for both HMN1 and HMN2 arrays have been submitted and accepted in European Bioinformatics Institutes (http://www.ebi.ac.uk), and their accession numbers are A-MEXP-361 and A-MEXP-362, respectively.

Quantitative Polymerase Chain Reaction Analysis

The ABI Prism 7700 sequence detection system (TaqMan; Applied Biosystems, Warrington, Cheshire, UK) was used to perform real-time polymerase chain reactions according to the manufacturer’s protocols. Ct values for each transcript were compared with those for 18S ribosomal RNA, which according to the gene array results remained relatively constant in abundance. All primers and probes were obtained from Applied Biosystems, Assays-on-Demand, and used a 5′-FAM reporter and 3′-nonfluorescent minor groove binder. The thermocycler parameters were 2 minutes at 50°C, followed by 40 cycles of 15 seconds 95°C and 1 minute at 60°C for PCR amplification.

Statistical Analysis

All data are presented as means ± SEM. Statistical analysis was performed using Statview (SAS Institute Inc., Cary, NC). Western blot measurements were analyzed using analysis of variance, and significant differences between groups were identified using the protected least significant differences (PLSD) post hoc test at P < 0.05. Differences between two groups were evaluated using Student’s unpaired t-test. In all cases, results were considered significant at P < 0.05.

Results

Effect of Labor on Oxidative Stress and Antioxidant Enzymes

Expression of the heat shock proteins (Hsp27 and Hsp90) and peroxidation of lipids (anti-HNE) were used as markers of oxidative stress. The relative amount of Hsp90 was significantly increased in the long labor samples, whereas that of Hsp27 peaked in the short labor samples and then fell to nonlabored levels (Figure 1). IHC localized Hsp27 principally to the syncytiotrophoblast (see below, Figure 6A). The relative amount of HNE between the three groups was not significantly different when analyzed by analysis of variance because of the small sample number and large variability. However, there was an obvious trend indicating increased lipid peroxidation in labored samples, and the difference was significant when the cesarean controls were compared with all of the labor samples combined (P = 0.023 analyzed by Student’s t-test).

Figure 1.

Figure 1

Labor induces the expression of oxidative stress markers. Lysates from placentas delivered by CS or vaginally with short labor (<5 hours) or long labor (>15 hours) were immunoblotted with antibodies against Hsp27, Hsp90, and HNE. Immunoblotting with an anti-β-actin antibody served to normalize gel loading. Normalized results (±SE) are plotted, expressing cesarean controls as 100%. Different letters indicate groups that are significantly different using the PLSD test with P < 0.05. Bars indicate groupings of labor samples for comparison with cesarean samples using unpaired Student’s t-test. *P < 0.05.

Figure 6.

Figure 6

Immunostaining for Hsp27 (A), CuZn-SOD (B), COX-2 (C), TNF-α (D), sVEGF-R1 (E), PlGF (F), PAI-2 (G), and M30 (H) localized these markers principally to the syncytiotrophoblast.

Mn-SOD increased in the short labor samples but returned to control levels in long labor placentas (Figure 2). Catalase increased with labor duration, and there was also a significant difference in catalase expression between the two labor groups (Figure 2). The expression in Cu/Zn-SOD also seemed to increase with labor duration, but this trend was not statistically significant by analysis of variance (Figures 2 and 6B). There was no effect on glutathione peroxidase (Figure 2).

Figure 2.

Figure 2

The effect of labor on antioxidant enzyme expression. Lysates from placentas delivered by CS or vaginally with short labor (<5 hours) or long labor (>15 hours) were immunoblotted with antibodies against catalase, glutathione peroxidase (GPX1), Cu/Zn-SOD, and Mn-SOD. Immunoblotting with an anti-β-actin antibody served to normalize gel loading. Normalized results (±SE) are plotted, expressing cesarean controls as 100%. Different letters indicate groups that are significantly different using the PLSD test with P < 0.05. Bars indicate groupings of labor samples for comparison with cesarean samples using unpaired Student’s t-test. *P < 0.05.

Effect of Labor on Cytokines and COX-2 Expression

The NF-κB pathway has been implicated in responses to oxidative stress. Phosphorylation and subsequent degradation of the IκB protein allows translocation of NF-κB to the nucleus, where it regulates gene expression. The ratio of phosphorylated IκB to total protein increased markedly with the duration of labor, reflecting activation of the NF-κB pathway. There was a significant difference between the short and long labor samples (Figure 3).

Figure 3.

Figure 3

Effect of labor on the expression of inflammatory cytokines, leptin, and COX-2. Lysates from placentas delivered by CS or vaginally with short labor (<5 hours) or long labor (>15 hours) were immunoblotted and analyzed with anti-TNF-α, anti-IL-1β, anti-leptin, anti-COX-2, anti-phospho-IκB, and anti-IκB antibodies. All blots were reprobed with anti-β-actin to normalize gel loading, and normalized results (±SE) are plotted, expressing cesarean controls as 100%. Different letters indicate groups that are significantly different using the PLSD test with P < 0.05.

Activation of NF-κB suggests an increase of proinflammatory cytokines and COX-2 after labor. Western blots confirmed that TNF-α, IL-1β, leptin, and COX-2 were all significantly increased in labored placentas compared with cesarean controls. Of these, only COX-2 was significantly different between short and long labor (Figure 3). IHC demonstrated localization of COX-2 and TNF-α principally to the trophoblast (see Figure 6, C and D).

Effect of Labor on Angiogenic Regulators

We also examined the effect of labor on placental vascular endothelial growth factor (VEGF-A), its soluble receptor (sVEGF-R1), and placental growth factor (PlGF). VEGF-A increased during labor in a similar manner, and there was a significant difference between the two labor groups (Figure 4). Placental sVEGF-R1 was significantly increased in both the short and long labor samples, the increase being 2.5-fold in long labor samples compared with cesarean controls (Figure 4).

Figure 4.

Figure 4

Effect of labor on the expression of angiogenic factors. Lysates from placentas delivered by CS or vaginally with short labor (<5 hours) or long labor (>15 hours) were immunoblotted and analyzed with anti-HIF-1α, anti-sVEGF-R1, anti-VEGF-A, anti-PlGF, and anti-PAI-2 antibodies. All blots were reprobed with anti-β-actin to normalize gel loading, and normalized results (±SE) are plotted, expressing cesarean controls as 100%. Different letters indicate groups that are significantly different using the PLSD test with P < 0.05.

HIF-1α has been implicated in the regulation of both these proteins,16 and we found that HIF-1α increased with the duration of labor, reaching statistical significance in the long labor samples (Figure 4). In contrast, PlGF decreased with labor duration, the difference reaching statistical significance in the long labor samples. HIF-1α and PlGF expression was significantly different between long labor and short labor. Plasminogen activator inhibitor type 2 (PAI-2) showed a trend toward a decrease in the long labor samples, but the differences failed to reach statistical significance (Figure 4). IHC localized the immunoreactivity of sVEGF-R1 (Figure 6E), PlGF (Figure 6F), and PAI-2 (Figure 6G) principally to the syncytiotrophoblast.

Proapoptotic Effects of Labor

Both TNF-α and IL-1β are known to be proapoptotic, and their elevation may lead to an increase of apoptosis in placental tissues subjected to labor. Consistent with this hypothesis, there was a significant increase in levels of cleaved caspase-3 and cleaved caspase-9 in the labored samples, with no significant difference between the two labor groups (Figure 5). Cleaved PARP also showed a strong trend toward an increase in the long labor samples, but analysis of variance was not significant (P = 0.078) because of large sample variation. It is important to note that IHC staining for M30 confirmed trophoblast apoptosis after labor (Figure 6H). To summarize, the above results clearly show an increase in oxidative stress, production of inflammatory cytokines and soluble VEGF-R1, and trophoblastic apoptosis in the placenta during labor.

Figure 5.

Figure 5

Labor induces apoptosis. Lysates from placentas delivered by CS or vaginally with short labor (<5 hours) or long labor (>15 hours) were immunoblotted and analyzed with anti-cleaved caspase-3, anti-cleaved caspase-9, and anti-cleaved PARP antibodies. All blots were reprobed with anti-β-actin to normalize gel loading and normalized results (±SE) are plotted, expressing cesarean controls as 100%. Different letters indicate groups that are significantly different using the PLSD test with P < 0.05.

Changes in the Placental Transcriptome during Labor

cDNA microarray analysis was performed using custom-made human cDNA arrays containing ∼15,000 probes in total. Placentas from uncomplicated normal pregnancies were used: seven from women undergoing labor longer than 15 hours and 10 from women undergoing elective CS. After normalization of the raw data from all 17 with LIMMA, the data were analyzed using Cyber-T. The conditions were tuned by repeated random sampling of the data, and parameters were chosen that resulted in a false discovery rate of less than 6%. Ninety transcripts were found to be significantly altered in their expression levels by >1.35-fold: 55 transcripts were found to be up-regulated and 35 transcripts to be down-regulated. The regulated transcripts were assigned to functional subsets by ontology analysis, and a portion of this is shown in Table 2. Additional details relating to all of the regulated transcripts are shown in Supplemental Table 1 (available online at http://ajp.amjpathol.org). We randomly selected eight genes that changed during labor and analyzed them by reverse transcriptase (RT)-PCR to confirm our results (Supplemental Table 2, available online at http://ajp.amjpathol.org). These genes included PAI-2, DnaJ, NDRG1, FOS, NFIL3, leptin, ELK1, and ASK-1, and their RT-PCR analysis confirmed the gene array data (Supplemental Figure 1 and Supplemental Table 3, available at http://ajp.amjpathol.org).

Table 2.

Regulated Transcripts Assigned to Functional Subsets by Ontology Analysis

Fold change Product
Response to stress
 SOD1 −1.61 Superoxide dismutase 1, soluble
 HSPA6 2.25 Heat shock 70-kd protein 6 (HSP70B)
 CSNK1E 1.66 Casein kinase 1 ε
 MAP3K5 6.97 Mitogen-activated protein kinase kinase kinase 5
 HSPA1L 2.35 Heat shock 70-kd protein 1-like
 CIRBP −1.55 Cold-inducible RNA binding protein
 DUSP1 2.76 Dual specificity phosphatase 1
 100A8 2.12 S100 calcium-binding protein A8 (calgranulin A)
 PLAT 2.05 Plasminogen activator, tissue
 SPP1 −4.10 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I)
 CTGF 2.15 Connective tissue growth factor
 HSPA1A 3.57 Heat shock 70-kd protein 1A
 PX3 2.29 Glutathione peroxidase 3, plasma
 THBS1 2.47 Thrombospondin 1
 CD59 −1.63 CD59 antigen p18-20
 FOS 4.96 v-fos FBJ murine osteosarcoma viral oncogene homolog
 PAI −3.10 Human placental plasminogen activator inhibitor
 VWF 1.57 von Willebrand factor
 NDRG1 3.58 N-myc downstream regulated gene
 DnaJ 1.91 Homolog subfamily B member 1 (Hsp40)
Cell surface receptor-linked signal transduction
 CTGF 2.15 Connective tissue growth factor
 ITGAV −1.48 Integrin α-V precursor
 PLAT 2.05 Plasminogen activator, tissue
 CALM2 2.42 Calmodulin 2
 CALCR 2.53 Calcitonin receptor
 FZD5 −1.67 Transmembrane receptor
 CALM1 2.17 Calmodulin 1 (phosphorylase kinase, δ)
 CXCR4 1.49 Chemokine (C-X-C motif) receptor 4
 FLT1 5.13 fms-related tyrosine kinase 1 (vascular endothelial growth factor receptor)
 CD59 −1.63 CD59 antigen p18-20
 LF6 1.60 COPEB protein
 FKBIA 1.77 Nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, α
Regulation of transcription
 HIRA −1.50 HIR histone cell-cycle regulation defective homolog A (S. cerevisiae)
 HMGB3 1.98 High-mobility group box 3
 KLF6 1.60 COPEB protein
 RAB26 −3.28 RAB26, member RAS oncogene family
 ZNF614 2.81 Hypothetical protein FLJ21941
 TAF1 2.11 TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250 kd
 FOS 4.96 v-fos FBJ murine osteosarcoma viral oncogene homolog
 FOSL2 1.62 FOS-like antigen 2
 NFIL3 1.78 Nuclear factor, interleukin 3 regulated
 ELK1 −1.57 ELK1
Immune system process
 NFIL3 1.78 Nuclear factor, interleukin 3 regulated
 KLF6 1.60 COPEB protein
 GTPBP1 2.36 HSPC018 protein
 SPP1 −4.10 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I)
 CD59 −1.63 CD59 antigen p18-20
 LEP 3.54 Leptin (obesity homolog, mouse)
 NFKBIA 1.77 Nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, α
 LYN 2.33 v-yes-1 Yamaguchi sarcoma viral-related oncogene homolog
 XCR4 1.49 Chemokine (C-X-C motif) receptor 4
Blood vessel development
 PGF −1.67 Placental growth factor
 CTGF 2.15 Connective tissue growth factor
 FLT1 5.13 fms-related tyrosine kinase 1 (vascular endothelial growth factor receptor)
 ITGAV −1.48 Integrin α-V precursor
 CXCR4 1.49 Chemokine (C-X-C motif) receptor 4
 THBS1 2.47 Thrombospondin 1
 CYR61 2.16 Cysteine-rich, angiogenic inducer, 61
 PAI −3.10 Human placental plasminogen activator inhibitor
Death
 HSPA1A 3.57 Heat shock 70-kd protein 1A
 NFKBIA 1.77 Nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, α
 SERPINB2 −2.24 Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2, plasminogen activator inhibitor 2
 MAP3K5 6.97 Mitogen-activated protein kinase kinase kinase 5 (ASK1)
 CASP4 −1.47 Ich-2
 FOSL2 1.62 FOS-like antigen 2
 PP1 −4.10 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I)
Cell adhesion
 ITGAV −1.48 Integrin α-V precursor
 VWF 1.57 von Willebrand factor
 CTGF 2.15 Connective tissue growth factor
 HBS4 2.62 Thrombospondin 4
 THBS1 2.47 Thrombospondin 1
 SPP1 −4.10 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I)
 CYR61 2.16 Cysteine-rich, angiogenic inducer, 61
Cell-cell signaling
 LEP 3.54 Leptin (obesity homolog, mouse)
 PP1 −4.10 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I)
 GF −1.67 Placental growth factor
 MAOA −1.74 Monoamine oxidase A
 SLC6A8 1.61 Creatine transporter
 CGA −1.44 Glycoprotein hormones, α polypeptide
 INSL4 −1.44 Insulin-like 4 (placenta)
Coagulation
 VWF 1.57 von Willebrand factor
 CD59 −1.63 CD59 antigen p18-20
 LAT 2.05 Plasminogen activator, tissue
 THBS1 2.47 Thrombospondin 1
 PAI −3.10 Human placental plasminogen activator inhibitor
Oxygen and reactive oxygen species metabolic process
 SOD1 −1.61 Superoxide dismutase 1, soluble
 PX3 2.29 Glutathione peroxidase 3, plasma
 FMO2 −1.44 Flavin-containing mono-oxygenase 2
 DUSP1 2.76 Dual-specificity phosphatase 1
Branching morphogenesis of a tube
 CYR61 2.16 Cysteine-rich, angiogenic inducer, 61
 CXCR4 1.49 Chemokine (C-X-C motif) receptor 4
 FLT1 5.13 fms-related tyrosine kinase 1 (vascular endothelial growth factor receptor)
 PGF −1.67 Placental growth factor

Tissue and cellular regulation depends on the interaction and co-regulation of numerous factors. Gene array analysis allows identification of many of the transcripts that form a part of this complex regulatory network. Analysis of the transcripts we identified as being significantly regulated with Ingenuity Pathway Analysis software revealed that there are numerous known relationships described in the existing literature connecting many of these transcripts. For example, as shown in Figure 7, several transcripts encoding proteins produced by, or acting on, endothelial cells are clearly connected [placenta growth factor (PGF), fms-like tyrosine kinase/VEGF-R1 (FLT1), von Willebrand factor (VWF), thrombospondin 1 (THBS1), and integrin α V (ITGAV)]. The ontology analysis also groups these transcripts as involved in blood vessel development. It was notable that the transcripts encoding leptin and VEGF-R1 were increased, and those encoding PlGF and PAI-2 were decreased, supporting the protein and IHC data. Several transcripts encoding enzymes involved in the cellular response to stress were also regulated and identified in the GO analysis.

Figure 7.

Figure 7

Ingenuity pathway analysis showing regulatory relationships among differentially expressed transcripts. Nodes marked in red indicate transcripts that are increased in prolonged labor relative to CS and those in green, the transcripts that are decreased. Transcripts marked with an asterisk were represented several times in the list of differentially expressed genes, each incidence being derived from a different probe on the microarray. The color intensity reflects the magnitude of the difference. The shape of the symbol denotes the type of protein encoded. Analysis was performed using software from Ingenuity.

Discussion

In this study, we compared samples from placentas delivered vaginally to nonlabored controls delivered by elective CS. We examined a panel of oxidative stress, angiogenic, proinflammatory, and apoptotic markers, and further divided the vaginally delivered placentas into two groups depending on the duration of labor, short labor (<5 hours) and long labor (>15 hours). We could thus study the effect of labor as well as the duration of labor on the placenta. To compare between groups it was important to load all samples on the same gel. We were thus restricted to examine just five samples per group. We repeated our protein probing several times, using different samples, and are satisfied that, despite intersample variations, the reported changes are genuine. Microarray analysis of ∼15,000 placental transcripts was also performed on the long labor samples. We found evidence of increased oxidative stress, activation of the NF-κB pathway and an increase in COX-2 and proinflammatory cytokines, stabilization of HIF-1α and increased tissue concentrations of soluble VEGF-R1 and VEGF-A, decreased tissue concentration of PlGF, and increased activation of apoptosis in labored placentas. The expression of most of these markers increased or decreased in relation to the duration of labor. Changes in the transcript levels supported the protein and IHC data. Not all protein changes were matched by equivalent changes in mRNA, but this is not surprising because many stimuli induce protein changes through translational mechanisms and have no effect on the transcript levels. For example, HIF-1α and -2α protein but not mRNA are increased in the syncytiotrophoblast, villous cytotrophoblast, and fetoplacental vasculature in the first trimester.27

There were differences in the degree of expression of several markers, including Hsp27, Hsp90, catalase, COX-2, P-IκB/IκB, HIF-1α, VEGF, and PlGF, between short labor and long labor. The data presented here suggest that the duration of labor increases the severity of the impact, which is to be expected. However, there were a few protein markers, including Hsp27, MnSOD, TNF-α, and IL-1β, that were only significantly increased in the short labor samples. The increase of Hsp27 and MnSOD may reflect a transient compensatory mechanism to deal with increasing oxidative stress. These defense mechanisms could be exhausted as the duration of labor continues. Why tissue levels of TNF-α and IL-1β were highest in short labor samples is less clear, but we speculate these cytokines are secreted into the maternal circulation as labor progresses, thus depleting tissue levels.

Because our study was based on human patients, we cannot completely separate the endocrine and hemodynamic effects of labor on the placenta. However, there is no doubt that the uterine contractions associated with labor provide the basis for ischemia-reperfusion type injury to the placenta. Doppler ultrasound studies have demonstrated a linear inverse relationship between uterine artery resistance and the intensity of the uterine contractions during labor.14 This can lead to complete absence of end-diastolic flow when the intrauterine pressure exceeds 35 mmHg.15 As shown in chronically instrumented pregnant rhesus monkeys, sustained myometrial contractions lead to near complete cessation of placental blood flow through compression of the arcuate and spiral arteries.16 Once uterine contractions have subsided, reperfusion of placental tissues ensues, which can result in tissue hyperemia and the generation of reactive oxygen species.28 Equivalent systematic investigation is not possible in the human, but angiographic studies performed at 17 to 20 weeks of gestation in patients before termination of pregnancy indicate that the same phenomenon occurs. Contrast medium introduced into the aorta entered the intervillous space within 4 to 5 seconds in the relaxed state, whereas during contractions induced with oxytocin or intra-amniotic injections of saline, entry was only observed in ∼50% of cases.29 Furthermore, the number of entry sites was reduced during contractions, as was the volume of contrast medium discharged. This intermittent perfusion can be expected to provide the basis for ischemia-reperfusion injury of the placenta, and the finding that labor is associated with increased xanthine oxidase activity in the placenta confirms that the insult does occur in vivo.17

We have previously shown that induction of oxidative stress in placental explants stimulates production of inflammatory cytokines and angiogenic regulators.9 The present study confirms that similar changes are induced physiologically in vivo during labor. In accordance with our results, placental production of both IL-1β and TNF-α have been reported to be elevated in labor.30,31 These cytokines activate the PG biosynthetic pathway primarily via the induction of COX-2, activating members of the NF-κB family of transcription factors, and the SAPK, ERK1/2, and p38 MAPK cascades. In our study, the marked increase in COX-2 in placental tissue subjected to labor was associated with activation of the NF-κB pathway, suggesting a possible involvement of this pathway. Similarly, a constitutive increase of NF-κB activity was seen in human amnion cells harvested after labor, which functions to increase the COX-2 expression and seems to contribute to the functional progesterone withdrawal through an interaction with the progesterone receptor.32 Placental production of PGs may therefore serve to initiate or augment uterine contractions during delivery in a feed-forward manner. A similar relationship between oxidative stress and increased concentrations of COX enzymes has recently been reported in the murine placenta.33

Labor was also associated with significant increases in both the transcript levels and protein levels of leptin in the placenta. Plasma concentrations of leptin rise significantly during pregnancy and decrease dramatically after delivery, suggesting the placenta is a major source of secretion.34,35,36 In agreement with our findings, a recent study showed maternal plasma leptin concentration increased significantly in pregnant women during the course of labor.37 In addition, IL-1β and TNF-α treatment significantly stimulated leptin secretion and mRNA expression in placental explants and BeWo cells in vitro, suggesting cytokine involvement in leptin secretion during labor.37

It is believed that VEGF-A, PlGF, and their receptor family are key components in regulating angiogenesis and trophoblast survival. A growing body of evidence indicates that soluble fms-like tyrosine kinase-1 (sFLT-1, sVEGF-R1), a naturally occurring circulating antagonist of VEGF-A and PlGF, is one of the secreted factors involved in the pathogenesis of preeclampsia.38 Elevated placental oxidative stress is thought to play a key role by stimulating the release of factors that cause activation of the maternal endothelium.39 sVEGF-R1 is increased in maternal serum and the placenta of preeclamptic patients and will reduce availability of VEGF-A, a potent endothelial-specific angiogenic mitogen40 and survival factor.41

We found the expression of sVEGF-R1 increased significantly in labored samples in a time-dependent manner. In women who develop preeclampsia, sVEGF-R1–1 rises sharply ∼5 weeks before the onset of clinical disease.42 This increase is accompanied by a decrease in free PlGF and free VEGF-A levels. In trophoblasts cultured under hypoxic conditions, VEGF-A expression and production increase while PlGF expression and production decrease.43 Similar findings were seen in our study, where in parallel with increased sVEGF-R1 mRNA and tissue protein level, placental VEGF-A increased but that of PlGF (both mRNA and protein) decreased in labored samples. Gerber and colleagues44 reported that VEGF-R1 receptor gene, but not the KDR/Flk-1 gene, is directly up-regulated by hypoxia via a hypoxia-inducible enhancer element, which includes a heptamer sequence matching the HIF-1 consensus binding site previously found in other hypoxia-inducible genes such as the VEGF-A gene and erythropoietin gene. In our study, HIF-1α expression was increased in labored samples, which suggests its involvement in the regulation of sVEGF-R1 and VEGF-A in labor. HIF-1α stability is increased by hypoxia, but it can also be up-regulated under nonhypoxic conditions by inflammatory cytokines or microtubule-depolymerizing agents involving the NF-κB pathway.45,46,47 Our findings are consistent with other studies that report that cytokine-mediated HIF-1 activation leads to production of VEGF-A and seems to proceed via a pathway involving up-stream PI-3K/Akt/mTOR pathway, NF-κB activation, and also COX-2 expression.45

Oxidative stress and inflammatory cytokines are powerful inducers of both apoptotic and necrotic changes in many systems. In this study, we found that labor led to a significant increase in the incidence of apoptosis in the trophoblast, as evidenced by the cleavage of cytokeratin filaments. We have previously demonstrated that hypoxia-reoxygenation in vitro is a potent stimulus of apoptosis in the syncytiotrophoblast and that apoptosis can be modulated by the addition of anti-oxidant molecules.9,10,12 In the context of vaginal delivery of the placenta, cell death may be of little physiological consequence because by this time the placenta will have completed its function. However, our results confirm that intermittent perfusion of the placenta is an adequate stimulus for apoptotic changes and so could account for the increased incidence of cell death observed in preeclamptic placentas.48,49 Deportation of apoptotic debris has been implicated in the pathophysiology of preeclampsia through activation of the maternal endothelial cells.50

In conclusion, we have demonstrated that labor leads to increased oxidative stress, induction of inflammatory and angiogenic regulators, and increased incidence of apoptosis in the human placenta. Many of these changes intensify with labor duration and are consistent with ischemia-reperfusion injury. Microarray analysis revealed changes in several transcripts, including those encoding leptin, VEGF-R1, PLAT, von Willebrand factor, PlGF, PAI-2 (SEPINB2), and MAO-A.51,52,53,54,55,56,57 The gene array analysis presented here, and the regulatory relationships described in Figure 7, indicate that placental oxidative stress has the potential to alter the development or behavior of the placental vasculature. This is consistent with the situation we have previously described at the end of the first trimester when there is a burst of placental oxidative stress at a time when placental vascular development is occurring.58 The transcripts changed in the same direction as observed in preeclampsia, suggesting that the placenta responds similarly to the oxidative stress induced during labor and in preeclampsia. This agreement suggests that the placental pathology can develop rapidly in preeclampsia, which may account for the sudden onset of the syndrome. It may also account for the fact that both preeclampsia and eclampsia may first present during labor or in the immediate puerperium.59 It can thus be proposed that labor could serve as an in vivo model of an acute ischemia-reperfusion injury to investigate and understand placental changes occurring in preeclampsia. Finally, our findings indicate that in many respects a vaginally delivered placenta does not accurately reflect the organ’s normal in vivo state. Consequently, we caution against the use of such placentas for biochemical and molecular studies.

Supplementary Material

Supplemental Material

Footnotes

Address reprint requests to Professor Graham J. Burton, Department of Physiology, Development, and Neuroscience, Downing St., Cambridge CB2 3DY, UK. E-mail: gjb2@cam.ac.uk.

Supported by the Wellcome Trust (grant 069027/Z/02/Z) and Tommy’s, the Baby Charity.

G.J.B. and D.S.C.-J. contributed equally to the study.

Supplemental material for this article can be found on http://ajp. amjpathol.org.

References

  1. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999;222:222–235. doi: 10.1177/153537029922200305. [DOI] [PubMed] [Google Scholar]
  2. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004;122:369–382. doi: 10.1007/s00418-004-0677-x. [DOI] [PubMed] [Google Scholar]
  3. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Invest. 2004;11:342–352. doi: 10.1016/j.jsgi.2004.03.003. [DOI] [PubMed] [Google Scholar]
  4. Brosens IA. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol. 1977;4:573–593. [PubMed] [Google Scholar]
  5. Kim YM, Bujold E, Chaiworapongsa T, Gomez R, Yoon BH, Thaler HT, Rotmensch S, Romero R. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2003;189:1063–1069. doi: 10.1067/s0002-9378(03)00838-x. [DOI] [PubMed] [Google Scholar]
  6. Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, Thaler HT, Romero R. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol. 2002;187:1137–1142. doi: 10.1067/mob.2002.127720. [DOI] [PubMed] [Google Scholar]
  7. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu. 1972;1:177–191. [PubMed] [Google Scholar]
  8. Hung T-H, Skepper JN, Burton GJ. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol. 2001;159:1031–1043. doi: 10.1016/S0002-9440(10)61778-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cindrova-Davies T, Spasic-Boskovic O, Jauniaux E, Charnock-Jones DS, Burton GJ. NF-κB, p38 and stress activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress. Am J Pathol. 2007;170:1511–1520. doi: 10.2353/ajpath.2007.061035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hung T-H, Skepper JN, Charnock-Jones DS, Burton GJ. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res. 2002;90:1274–1281. doi: 10.1161/01.res.0000024411.22110.aa. [DOI] [PubMed] [Google Scholar]
  11. Hung T-H, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-α from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potent mediator of the inflammatory response in preeclampsia. Am J Pathol. 2004;164:1049–1061. doi: 10.1016/s0002-9440(10)63192-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tjoa M-L, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol. 2006;169:400–404. doi: 10.2353/ajpath.2006.060161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bainbridge SA, Belkacemi L, Dickinson M, Graham CH, Smith GN. Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Am J Pathol. 2006;169:774–783. doi: 10.2353/ajpath.2006.060184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Brar HS, Platt LD, DeVore GR, Horenstein J, Medearis AL. Qualitative assessment of maternal uterine and fetal umbilical artery blood flow and resistance in laboring patients by Doppler velocimetry. Am J Obstet Gynecol. 1988;158:952–956. doi: 10.1016/0002-9378(88)90100-7. [DOI] [PubMed] [Google Scholar]
  15. Fleischer A, Anyaegbunam AA, Schulman H, Farmakides G, Randolph G. Uterine and umbilical artery velocimetry during normal labor. Am J Obstet Gynecol. 1987;157:40–43. doi: 10.1016/s0002-9378(87)80342-3. [DOI] [PubMed] [Google Scholar]
  16. Ramsey E, Donner M. Placental vasculature and circulation. Stuttgart: Georg Thieme Publishers Stuttgart,; Anatomy, Physiology, Radiology, Clinical Aspects Atlas and Textbook. 1980 [Google Scholar]
  17. Many A, Roberts JM. Increased xanthine oxidase during labour—implications for oxidative stress. Placenta. 1997;18:725–726. doi: 10.1016/s0143-4004(97)90015-1. [DOI] [PubMed] [Google Scholar]
  18. Bloxam DL, Bobinski PM. Energy metabolism and glycolysis in the human placenta during ischaemia and in normal labour. Placenta. 1984;5:381–394. doi: 10.1016/s0143-4004(84)80018-1. [DOI] [PubMed] [Google Scholar]
  19. Woods JR, Cavanaugh JL, Normkus EP, Plessinger MA, Miller RK. The effect of labor on maternal and fetal vitamins C and E. Am J Obstet Gynecol. 2002;187:1179–1183. doi: 10.1067/mob.2002.127131. [DOI] [PubMed] [Google Scholar]
  20. Raijmakers MT, Roes EM, Steegers EA, van der Wildt B, Peters WH. Umbilical glutathione levels are higher after vaginal birth than after cesarean section. J Perinatal Med. 2003;31:520–522. doi: 10.1515/JPM.2003.079. [DOI] [PubMed] [Google Scholar]
  21. Kniss DA. Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Invest. 1999;6:285–292. doi: 10.1016/s1071-5576(99)00034-9. [DOI] [PubMed] [Google Scholar]
  22. Philpott RH, Castle WM. Cervicographs in the management of labour in primigravidae. I. The alert line for detecting abnormal labour. J Obstet Gynaecol Br Commonw. 1972;79:592–598. doi: 10.1111/j.1471-0528.1972.tb14207.x. [DOI] [PubMed] [Google Scholar]
  23. Philpott RH, Castle WM. Cervicographs in the management of labour in primigravidae. II. The action line and treatment of abnormal labour. J Obstet Gynaecol Br Commonw. 1972;79:599–602. doi: 10.1111/j.1471-0528.1972.tb14208.x. [DOI] [PubMed] [Google Scholar]
  24. Hung SP, Baldi P, Hatfield GW. Global gene expression profiling in Escherichia coli K12: effects of leucine-responsive regulatory protein. J Biol Chem. 2002;277:40309–40323. doi: 10.1074/jbc.M204044200. [DOI] [PubMed] [Google Scholar]
  25. Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics. 2001;17:509–519. doi: 10.1093/bioinformatics/17.6.509. [DOI] [PubMed] [Google Scholar]
  26. Al-Shahrour F, Diaz-Uriarte R, Dopazo J. FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics. 2004;20:578–580. doi: 10.1093/bioinformatics/btg455. [DOI] [PubMed] [Google Scholar]
  27. Rajakumar A, Conrad KP. Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol Reprod. 2000;63:559–569. doi: 10.1095/biolreprod63.2.559. [DOI] [PubMed] [Google Scholar]
  28. McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem. 1993;26:351–357. doi: 10.1016/0009-9120(93)90111-i. [DOI] [PubMed] [Google Scholar]
  29. Borell U, Fernstroem I, Ohlson L, Wiqvist N. Influence of uterine contractions on the uteroplacental blood flow at term. Am J Obstet Gynecol. 1965;93:44–57. doi: 10.1016/0002-9378(65)90293-0. [DOI] [PubMed] [Google Scholar]
  30. Romero R, Mazor M, Brandt F, Sepulveda W, Avila C, Cotton DB, Dinarello CA. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol. 1992;27:117–123. doi: 10.1111/j.1600-0897.1992.tb00737.x. [DOI] [PubMed] [Google Scholar]
  31. Opsjłn SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol. 1993;169:397–404. doi: 10.1016/0002-9378(93)90096-2. [DOI] [PubMed] [Google Scholar]
  32. Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR. Human labour is associated with nuclear factor-κB activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal’. Mol Hum Reprod. 2001;7:581–586. doi: 10.1093/molehr/7.6.581. [DOI] [PubMed] [Google Scholar]
  33. Burdon C, Mann C, Cindrova-Davies T, Ferguson-Smith AC, Burton GJ. Oxidative stress and the induction of cyclooxygenase enzymes and apoptosis in the murine placenta. Placenta. 2007;28:724–733. doi: 10.1016/j.placenta.2006.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol. 1998;178:1010–1015. doi: 10.1016/s0002-9378(98)70540-x. [DOI] [PubMed] [Google Scholar]
  35. Lage M, Garcia-Mayor RV, Tome MA, Cordido F, Valle-Inclan F, Considine RV, Caro JF, Dieguez C, Casanueva FF. Serum leptin levels in women throughout pregnancy and the postpartum period and in women suffering spontaneous abortion. Clin Endocrinol (Oxf) 1999;50:211–216. doi: 10.1046/j.1365-2265.1999.00637.x. [DOI] [PubMed] [Google Scholar]
  36. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3:1029–1033. doi: 10.1038/nm0997-1029. [DOI] [PubMed] [Google Scholar]
  37. Nuamah MA, Yura S, Sagawa N, Itoh H, Mise H, Korita D, Kakui K, Takemura M, Ogawa Y, Nakao K, Fujii S. Significant increase in maternal plasma leptin concentration in induced delivery: a possible contribution of pro-inflammatory cytokines to placental leptin secretion. Endocr J. 2004;51:177–187. doi: 10.1507/endocrj.51.177. [DOI] [PubMed] [Google Scholar]
  38. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–658. doi: 10.1172/JCI17189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594. doi: 10.1126/science.1111726. [DOI] [PubMed] [Google Scholar]
  40. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol. 2002;20:4368–4380. doi: 10.1200/JCO.2002.10.088. [DOI] [PubMed] [Google Scholar]
  41. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem. 1998;273:30336–30343. doi: 10.1074/jbc.273.46.30336. [DOI] [PubMed] [Google Scholar]
  42. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–683. doi: 10.1056/NEJMoa031884. [DOI] [PubMed] [Google Scholar]
  43. Li H, Gu B, Zhang Y, Lewis DF, Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta. 2005;26:210–217. doi: 10.1016/j.placenta.2004.05.004. [DOI] [PubMed] [Google Scholar]
  44. Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem. 1997;272:23659–23667. doi: 10.1074/jbc.272.38.23659. [DOI] [PubMed] [Google Scholar]
  45. Jung Y-J, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1β mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 2003;17:2115–2117. doi: 10.1096/fj.03-0329fje. [DOI] [PubMed] [Google Scholar]
  46. Jung Y-J, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappaB activation. Biochem J. 2003;370:1011–1017. doi: 10.1042/BJ20021279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Jung Y-J, Isaacs JS, Lee S, Trepel J, Neckers L. Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein. J Biol Chem. 2003;278:7445–7452. doi: 10.1074/jbc.M209804200. [DOI] [PubMed] [Google Scholar]
  48. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol. 2000;96:271–276. doi: 10.1016/s0029-7844(00)00895-4. [DOI] [PubMed] [Google Scholar]
  49. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2001;184:1249–1250. doi: 10.1067/mob.2001.112906. [DOI] [PubMed] [Google Scholar]
  50. Redman CWG, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21:597–602. doi: 10.1053/plac.2000.0560. [DOI] [PubMed] [Google Scholar]
  51. Li RH, Poon SC, Yu MY, Wong YF. Expression of placental leptin and leptin receptors in preeclampsia. Int J Gynecol Pathol. 2004;23:378–385. doi: 10.1097/01.pgp.0000139647.40620.c8. [DOI] [PubMed] [Google Scholar]
  52. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Halmesmaki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod. 2001;7:205–210. doi: 10.1093/molehr/7.2.205. [DOI] [PubMed] [Google Scholar]
  53. Koh SC, Anandakumar C, Montan S, Ratnam SS. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia. Gynecol Obstet Invest. 1993;35:214–221. doi: 10.1159/000292703. [DOI] [PubMed] [Google Scholar]
  54. Deng L, Bremme K, Hansson LO, Blomback M. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol. 1994;84:941–945. [PubMed] [Google Scholar]
  55. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 1998;179:1539–1544. doi: 10.1016/s0002-9378(98)70021-3. [DOI] [PubMed] [Google Scholar]
  56. Reith A, Booth NA, Moore NR, Cruickshank DJ, Bennett B. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br J Obstet Gynaecol. 1993;100:370–374. doi: 10.1111/j.1471-0528.1993.tb12982.x. [DOI] [PubMed] [Google Scholar]
  57. Carrasco G, Cruz MA, Dominguez A, Gallardo V, Miguel P, Gonzalez C. The expression and activity of monoamine oxidase A, but not of the serotonin transporter, is decreased in human placenta from preeclamptic pregnancies. Life Sci. 2000;67:2961–2969. doi: 10.1016/s0024-3205(00)00883-3. [DOI] [PubMed] [Google Scholar]
  58. Jauniaux E, Watson AL, Hempstock J, Bao Y-P, Skepper JN, Burton GJ. Onset of maternal arterial blood flow placental oxidative stress; a possible factor in human early pregnancy failure. Am J Pathol. 2000;157:2111–2122. doi: 10.1016/S0002-9440(10)64849-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Chames MC, Livingston JC, Ivester TS, Barton JR, Sibai BM. Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol. 2002;186:1174–1177. doi: 10.1067/mob.2002.123824. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES